Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synta Pharmaceuticals Corp (NASDAQ:SNTA)

0.3615
Delayed Data
As of May 27
 +0.0009 / +0.25%
Today’s Change
0.15
Today|||52-Week Range
2.65
+2.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization168.0K166.0K159.0K46.0K
 
 
 
 
 
 
Operating ExpensesGross Income-168.0K-166.0K-159.0K-46.0K
 
 
 
 
 
General Expenses19.3M17.2M10.2M6.4M
 
 
 
 
 
Research And Development16.4M14.4M7.2M3.4M
 
 
 
 
 
Total Operating Expenses19.5M17.4M10.4M6.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.5M-17.4M-10.4M-6.4M
 
 
 
 
 
Interest Expense On Debt296.0K234.0K156.0K77.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.8M-17.6M-10.5M-6.5M
 
 
 
 
 
Net Income-19.8M-17.6M-10.5M-6.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS132.3M136.0M137.3M137.4M
 
 
 
 
 
Shares To Calculate EPS Diluted132.3M136.0M137.3M137.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.13-$0.08-$0.05
 
 
 
 
 
EPS Diluted-$0.15-$0.13-$0.08-$0.05